Stella M. Thompson

Molecular Medicine BioServices, Inc. is a company that provides services in the pharmaceutical industry. The company is based in Carlsbad, CA. The company has signed a manufacturing agreement with Cardium Therapeutics for the production of Generx and have expanded their services to better serve client vaccine development and testing needs. The company was acquired by Sigma-Aldrich Corp., part of Merck KGaA on November 19, 2015.

NGN Capital LLC (NGN Capital) is a venture capital firm founded in 2003 by Kenneth S. Abramowitz and William J. Gedale. The firm is headquartered in New York.

Vivaldi Biosciences Inc. develops and markets vaccines. It specializes in developing live attenuated influenza vaccines (LAIVs). The company was founded by Eliott Kieff, Peter Palese, and Adolfo García-Sastre in 2006 and is headquartered in Fort Collins, CO.

Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany.

Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999.

Felesky Flynn LLP provides legal services. The private company is based in Calgary, Canada.

NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany.

Horizon Therapeutics Schweiz GmbH is a biopharmaceutical company that develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company was originally founded in 2004 as a spin-out of Merck KGaA and is headquartered in Reinach, Switzerland.

Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT.

Ernst & Young LLP (Canada) engages in the provision of consulting, assurance, tax, and transaction services. The company is headquartered in Toronto, Canada.

Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD.

Tartan Canada Corp. provides industrial energy services. It services include plant and field maintenance, shutdowns, constructionand fabrication. The company was founded in 1953 and is headquartered in Calgary, Canada.

The Canadian Energy Pipeline Association is a domain that is currently for sale. The non-profit company does not have a physical location or any information about its operations. The website, cepa.com, is available for purchase for USD$6,999.00. Christopher John Charles Bloomer has not been mentioned in the provided metadata.

The Petroleum Joint Venture Association develops reports on various issues related to the petroleum industry. It specializes in joint venture agreements, oil and energy, GPAC/PJVA joint conference and natural gas. The company was founded in 1985 and is headquartered in Calgary, Canada.

Haworth Ltd. manufactures institutional furniture. The company was founded in 1977 and is headquartered in Toronto, Canada.

Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA.

ATCO Energy Solutions Ltd. builds, owns, and operates electrical, industrial pipelines, and hydrocarbon storage facilities. The firm offers pipelines and storage for hydrocarbons and related gas products, electric transmission and substations, water treatment, transmission, and distribution. The company was founded in 2008 and is headquartered in Calgary, Canada.

Part of AMETEK, Inc., RTDS Technologies, Inc. is a Canadian company that specializes in hardware-in-the-loop testing of protection and control equipment. The company is based in Winnipeg, Canada. The company's flagship product, the RTDS Simulator, is the world standard for real-time simulation in the power industry. The company is leaders in their field and are driving innovation in simulating the grid of tomorrow. The company's technology allows for the validation of novel technologies and improves operator confidence. RTDS Technologies was founded in 1989 and has been instrumental in changing the power industry with their introduction of the world's first fully digital real-time power system simulator. Neil Mackenzie, Trevor Maguire, Rudi Wierckx, James Giesbrecht, and Rick Kuffel founded the company in 1994, and Kelly McNeill has been the CEO since 2014. RTDS Technologies was acquired by AMETEK, Inc. on November 01, 2022 for $238.26 million.

Lumendi Ltd. develops medical devices for the treatment of gastrointestinal conditions. The private company is based in Maidenhead, UK. The British company was founded in 2014 by Peter Johann. Peter Johann has been the CEO since 2014.

ATCO Pipelines operates key natural gas transmission facilities throughout Alberta to transport clean, efficient energy from producers and other pipelines to utilities, power generators, and major industries. The company was founded in 1999 and is headquartered in Calgary, Canada.

Vivaldi Biosciences AG is a venture-backed company that focuses on research and development. It develops genetically engineered intranasal vaccines for epidemic and pandemic viral respiratory diseases. The company is headquartered in Vienna, Austria.